IPO Timeline
Broker Results (T-2)
2021-08-20
Some brokers release in afternoon
Grey Market (T-1)
2021-08-23
Afternoon
HKEX Allotment (T-1)
2021-08-23
Evening
Registrar Allotment (T-1)
2021-08-23
Evening
Listing Day (T)
2021-08-24
First day of trading
Company Overview
| Stock Name | 先瑞達醫療科技控股有限公司 - B |
|---|---|
| Stock Code | 06669 |
| Company Full Name | 先瑞達醫療科技控股有限公司 - B |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事醫療器械業務，重點開發血管介入醫療器械，治療領域包括血管外科、心臟科、腎臟科、神經科及男科。 |
| Listing Date | 2021-08-24 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市北京經濟技術開發區宏達北路16號1幢4至5層 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.acotec.cn |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 23.80 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 49.9% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 816,768,400 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 17.6 |
|---|---|
| First Day Open | HK$ 18.32 |
| First Day Change | -26.05% |
| First Day Volume | 31056400.0 |
| First Day Turnover | 552859000.0 |
Use of Proceeds
| Use of Proceeds | 1、32%（或約489.30百萬港元）將被分配予我們的核心產品； 2、23%（或約351.70百萬港元）將被分配予我們現有產品管線中余下的24款產品； 3、7%（或約107.0百萬港元）將用于擴大生產能力及強化制造能力； 4、24%（或約366.90百萬港元）將獲分配用于為通過（其中包括）內部研發、合作、合并及收購、授權引進或股權投資等方式擴大我們的產品組合提供資金； 5、8%（或約122.30百萬港元）將用于我們的營運資金及一般企業用途； 6、6%（或約91.70百萬港元）將用于償還2021年1月來自硅谷銀行的貸款。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (2)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
Joint Bookrunners (4)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
招商证券（香港）有限公司 CE AAI650
华盛资本证券有限公司 CE AUL711
Joint Lead Managers (4)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
招商证券（香港）有限公司 CE AAI650
华盛资本证券有限公司 CE AUL711
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Athos Asia Event Driven Master Fund | 38,817,800 HKD | — | 2.38% | — | 6 months | 2022-02-24 |
| 2 | CPE Investment Wu Limited | 77,659,400 HKD | — | 4.75% | — | 6 months | 2022-02-24 |
| 3 | Dymon Asia Capital (Singapore) Pte. Ltd. | 38,817,800 HKD | — | 2.38% | — | 6 months | 2022-02-24 |
| 4 | Perseverance Asset Management International (Singapore) Pte. Ltd. | 77,659,400 HKD | — | 4.75% | — | 6 months | 2022-02-24 |
| 5 | Primeone Luck Limited | 38,817,800 HKD | — | 2.38% | — | 6 months | 2022-02-24 |
| 6 | The Valliance Fund | 77,659,400 HKD | — | 4.75% | — | 6 months | 2022-02-24 |
| 7 | 保银资产管理有限公司 | 38,817,800 HKD | — | 2.38% | — | 6 months | 2022-02-24 |
| 8 | 达观国际有限公司 | 77,659,400 HKD | — | 4.75% | — | 6 months | 2022-02-24 |
| 9 | 汇添富基金管理股份有限公司 | 155,342,600 HKD | — | 9.51% | — | 6 months | 2022-02-24 |
| 10 | 盘京港景投资基金 | 38,817,800 HKD | — | 2.38% | — | 6 months | 2022-02-24 |
| 11 | 新里程医院集团有限公司 | 38,817,800 HKD | — | 2.38% | — | 6 months | 2022-02-24 |
| 12 | 易方达基金管理有限公司 | 38,817,800 HKD | — | 2.38% | — | 6 months | 2022-02-24 |
| 13 | 中国国际金融股份有限公司 | 77,659,400 HKD | — | 4.75% | — | 6 months | 2022-02-24 |
Directors & Management
| Chairman | 李靜 |
|---|---|
| Company Secretary | 李晨;李菁怡 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | CPEChina Fund III, L.P.(51.65%);李靜及關連人士(17.64%) |
|---|
IPO Timeline
